SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-023181
Filing Date
2024-06-07
Accepted
2024-06-07 17:15:40
Documents
1
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4137
  Complete submission text file 0001493152-24-023181.txt   5797
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Issuer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DARE BIOSCIENCE, INC. 11119 NORTH TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address
Grossman Jessica D. (Reporting) CIK: 0001736781 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36395 | Film No.: 241030677